PubMed:9619918
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-4 | protein | denotes | IL-2 |
| T2 | 23-64 | cell_type | denotes | CD8+ T cell prolymphocytic leukemia cells |
| T3 | 77-86 | protein | denotes | NF-kappaB |
| T4 | 101-120 | protein | denotes | IL-2 receptor alpha |
| T5 | 148-161 | protein | denotes | interleukin-2 |
| T6 | 163-167 | protein | denotes | IL-2 |
| T7 | 195-202 | cell_type | denotes | T cells |
| T8 | 233-254 | protein | denotes | nuclear factor kappaB |
| T9 | 256-265 | protein | denotes | NF-kappaB |
| T10 | 286-324 | DNA | denotes | IL-2 receptor (IL-2R) alpha chain gene |
| T11 | 384-389 | protein | denotes | IL-2R |
| T12 | 417-466 | cell_line | denotes | CD8+ T cell prolymphocytic leukemia (T-PLL) cells |
| T13 | 519-541 | cell_type | denotes | primary leukemia cells |
| T14 | 583-609 | protein | denotes | IL-2Ralpha and beta chains |
| T15 | 676-686 | protein | denotes | IL-2Ralpha |
| T16 | 725-729 | protein | denotes | IL-2 |
| T17 | 771-780 | RNA | denotes | IL-2 mRNA |
| T18 | 798-802 | protein | denotes | IL-2 |
| T19 | 906-910 | protein | denotes | IL-2 |
| T20 | 921-930 | protein | denotes | NF-kappaB |
| T21 | 975-989 | cell_type | denotes | leukemia cells |
| T22 | 1030-1034 | protein | denotes | IL-2 |
| T23 | 1081-1090 | protein | denotes | NF-kappaB |
| T24 | 1102-1107 | protein | denotes | c-Rel |
| T25 | 1112-1116 | protein | denotes | KBF1 |
| T26 | 1133-1137 | protein | denotes | IL-2 |
| T27 | 1173-1177 | protein | denotes | IL-2 |
| T28 | 1224-1230 | protein | denotes | IL-2Rs |
| T29 | 1238-1252 | cell_type | denotes | leukemia cells |
| T30 | 1289-1309 | protein | denotes | high-affinity IL-2Rs |
| T31 | 1335-1339 | protein | denotes | IL-2 |
| T32 | 1389-1398 | protein | denotes | NF-kappaB |
| T33 | 1402-1426 | cell_line | denotes | primary CD8+ T-PLL cells |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 23-64 | NP | denotes | CD8+ T cell prolymphocytic leukemia cells |
| C2 | 101-131 | NP | denotes | IL-2 receptor alpha expression |
| C3 | 148-168 | NP | denotes | interleukin-2 (IL-2) |
| C4 | 172-175 | NP | denotes | its |
| C5 | 211-266 | NP | denotes | nuclear expression of nuclear factor kappaB (NF-kappaB) |
| C6 | 417-466 | NP | denotes | CD8+ T cell prolymphocytic leukemia (T-PLL) cells |
| C7 | 519-572 | NP | denotes | primary leukemia cells from a patient with CD8+ T-PLL |
| C8 | 615-624 | NP | denotes | the cells |
| C9 | 676-697 | NP | denotes | IL-2Ralpha expression |
| C10 | 731-753 | NP | denotes | Northern blot analysis |
| C11 | 798-802 | NP | denotes | IL-2 |
| C12 | 971-989 | NP | denotes | the leukemia cells |
| C13 | 995-1017 | NP | denotes | Northern blot analysis |
| C14 | 1030-1034 | NP | denotes | IL-2 |
| C15 | 1120-1131 | NP | denotes | these cells |
| C16 | 1173-1177 | NP | denotes | IL-2 |
| C17 | 1234-1252 | NP | denotes | the leukemia cells |
| C18 | 1335-1339 | NP | denotes | IL-2 |
| C19 | 1363-1398 | NP | denotes | the nuclear expression of NF-kappaB |
| C20 | 1402-1426 | NP | denotes | primary CD8+ T-PLL cells |
| R1 | C4 | C3 | coref-pron | its,interleukin-2 (IL-2) |
| R2 | C6 | C1 | coref-ident | CD8+ T cell prolymphocytic leukemia (T-PLL) cells,CD8+ T cell prolymphocytic leukemia cells |
| R3 | C8 | C7 | coref-ident | the cells,primary leukemia cells from a patient with CD8+ T-PLL |
| R4 | C9 | C2 | coref-ident | IL-2Ralpha expression,IL-2 receptor alpha expression |
| R5 | C11 | C3 | coref-ident | IL-2,interleukin-2 (IL-2) |
| R6 | C12 | C8 | coref-ident | the leukemia cells,the cells |
| R7 | C13 | C10 | coref-ident | Northern blot analysis,Northern blot analysis |
| R8 | C14 | C11 | coref-ident | IL-2,IL-2 |
| R9 | C15 | C12 | coref-ident | these cells,the leukemia cells |
| R10 | C16 | C14 | coref-ident | IL-2,IL-2 |
| R11 | C17 | C15 | coref-ident | the leukemia cells,these cells |
| R12 | C18 | C16 | coref-ident | IL-2,IL-2 |
| R13 | C19 | C5 | coref-ident | the nuclear expression of NF-kappaB,nuclear expression of nuclear factor kappaB (NF-kappaB) |
| R14 | C20 | C6 | coref-ident | primary CD8+ T-PLL cells,CD8+ T cell prolymphocytic leukemia (T-PLL) cells |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-132 | Sentence | denotes | IL-2-induced growth of CD8+ T cell prolymphocytic leukemia cells mediated by NF-kappaB induction and IL-2 receptor alpha expression. |
| S2 | 133-349 | Sentence | denotes | The binding of interleukin-2 (IL-2) to its receptor on normal T cells induces nuclear expression of nuclear factor kappaB (NF-kappaB), activation of the IL-2 receptor (IL-2R) alpha chain gene, and cell proliferation. |
| S3 | 350-489 | Sentence | denotes | In the present study, the role of IL-2R signaling in the growth of CD8+ T cell prolymphocytic leukemia (T-PLL) cells has been investigated. |
| S4 | 490-730 | Sentence | denotes | Flow cytometry revealed that primary leukemia cells from a patient with CD8+ T-PLL expressed IL-2Ralpha and beta chains, and the cells showed a proliferative response and an increase in IL-2Ralpha expression on culture with exogeneous IL-2. |
| S5 | 731-841 | Sentence | denotes | Northern blot analysis failed to detect IL-2 mRNA, suggesting that IL-2 may act in a paracrine manner in vivo. |
| S6 | 842-1132 | Sentence | denotes | Electrophoretic mobility-shift assays revealed that recombinant IL-2 increased NF-kappaB binding activity in nuclear extracts of the leukemia cells, and Northern blot analysis showed that IL-2 increased the abundance of mRNAs encoding the NF-kappaB components c-Rel and KBF1 in these cells. |
| S7 | 1133-1310 | Sentence | denotes | IL-2 binding analysis demonstrated that IL-2 markedly increased the number of low affinity IL-2Rs on the leukemia cells, without an effect on the number of high-affinity IL-2Rs. |
| S8 | 1311-1508 | Sentence | denotes | These results show that IL-2 is capable of inducing the nuclear expression of NF-kappaB in primary CD8+ T-PLL cells, and that this effect is mediated, at least in part, at a pretranslational level. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-4 | protein_molecule | denotes | IL-2 |
| T2 | 23-64 | cell_type | denotes | CD8+ T cell prolymphocytic leukemia cells |
| T3 | 77-86 | protein_complex | denotes | NF-kappaB |
| T4 | 101-105 | protein_molecule | denotes | IL-2 |
| T5 | 148-161 | protein_molecule | denotes | interleukin-2 |
| T6 | 163-167 | protein_molecule | denotes | IL-2 |
| T7 | 195-202 | cell_type | denotes | T cells |
| T8 | 211-229 | other_name | denotes | nuclear expression |
| T9 | 233-254 | protein_complex | denotes | nuclear factor kappaB |
| T10 | 256-265 | protein_complex | denotes | NF-kappaB |
| T11 | 286-290 | protein_molecule | denotes | IL-2 |
| T12 | 330-348 | other_name | denotes | cell proliferation |
| T13 | 384-389 | protein_family_or_group | denotes | IL-2R |
| T14 | 417-466 | cell_line | denotes | CD8+ T cell prolymphocytic leukemia (T-PLL) cells |
| T15 | 519-541 | cell_type | denotes | primary leukemia cells |
| T16 | 562-572 | other_name | denotes | CD8+ T-PLL |
| T17 | 676-686 | protein_subunit | denotes | IL-2Ralpha |
| T18 | 725-729 | protein_molecule | denotes | IL-2 |
| T19 | 731-753 | other_name | denotes | Northern blot analysis |
| T20 | 771-780 | RNA_molecule | denotes | IL-2 mRNA |
| T21 | 798-802 | protein_molecule | denotes | IL-2 |
| T22 | 842-879 | other_name | denotes | Electrophoretic mobility-shift assays |
| T23 | 906-910 | protein_molecule | denotes | IL-2 |
| T24 | 921-930 | protein_complex | denotes | NF-kappaB |
| T25 | 951-967 | cell_component | denotes | nuclear extracts |
| T26 | 975-989 | cell_type | denotes | leukemia cells |
| T27 | 995-1017 | other_name | denotes | Northern blot analysis |
| T28 | 1030-1034 | protein_molecule | denotes | IL-2 |
| T29 | 1081-1090 | protein_complex | denotes | NF-kappaB |
| T30 | 1102-1107 | protein_molecule | denotes | c-Rel |
| T31 | 1112-1116 | protein_molecule | denotes | KBF1 |
| T32 | 1133-1137 | protein_molecule | denotes | IL-2 |
| T33 | 1173-1177 | protein_molecule | denotes | IL-2 |
| T34 | 1224-1230 | protein_family_or_group | denotes | IL-2Rs |
| T35 | 1238-1252 | cell_type | denotes | leukemia cells |
| T36 | 1289-1309 | protein_family_or_group | denotes | high-affinity IL-2Rs |
| T37 | 1335-1339 | protein_molecule | denotes | IL-2 |
| T38 | 1367-1385 | other_name | denotes | nuclear expression |
| T39 | 1389-1398 | protein_complex | denotes | NF-kappaB |
| T40 | 1402-1426 | cell_line | denotes | primary CD8+ T-PLL cells |
| T41 | 1485-1507 | other_name | denotes | pretranslational level |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-132 | Sentence | denotes | IL-2-induced growth of CD8+ T cell prolymphocytic leukemia cells mediated by NF-kappaB induction and IL-2 receptor alpha expression. |
| TextSentencer_T2 | 133-349 | Sentence | denotes | The binding of interleukin-2 (IL-2) to its receptor on normal T cells induces nuclear expression of nuclear factor kappaB (NF-kappaB), activation of the IL-2 receptor (IL-2R) alpha chain gene, and cell proliferation. |
| TextSentencer_T3 | 350-489 | Sentence | denotes | In the present study, the role of IL-2R signaling in the growth of CD8+ T cell prolymphocytic leukemia (T-PLL) cells has been investigated. |
| TextSentencer_T4 | 490-730 | Sentence | denotes | Flow cytometry revealed that primary leukemia cells from a patient with CD8+ T-PLL expressed IL-2Ralpha and beta chains, and the cells showed a proliferative response and an increase in IL-2Ralpha expression on culture with exogeneous IL-2. |
| TextSentencer_T5 | 731-841 | Sentence | denotes | Northern blot analysis failed to detect IL-2 mRNA, suggesting that IL-2 may act in a paracrine manner in vivo. |
| TextSentencer_T6 | 842-1132 | Sentence | denotes | Electrophoretic mobility-shift assays revealed that recombinant IL-2 increased NF-kappaB binding activity in nuclear extracts of the leukemia cells, and Northern blot analysis showed that IL-2 increased the abundance of mRNAs encoding the NF-kappaB components c-Rel and KBF1 in these cells. |
| TextSentencer_T7 | 1133-1310 | Sentence | denotes | IL-2 binding analysis demonstrated that IL-2 markedly increased the number of low affinity IL-2Rs on the leukemia cells, without an effect on the number of high-affinity IL-2Rs. |
| TextSentencer_T8 | 1311-1508 | Sentence | denotes | These results show that IL-2 is capable of inducing the nuclear expression of NF-kappaB in primary CD8+ T-PLL cells, and that this effect is mediated, at least in part, at a pretranslational level. |
| T1 | 0-132 | Sentence | denotes | IL-2-induced growth of CD8+ T cell prolymphocytic leukemia cells mediated by NF-kappaB induction and IL-2 receptor alpha expression. |
| T2 | 133-349 | Sentence | denotes | The binding of interleukin-2 (IL-2) to its receptor on normal T cells induces nuclear expression of nuclear factor kappaB (NF-kappaB), activation of the IL-2 receptor (IL-2R) alpha chain gene, and cell proliferation. |
| T3 | 350-489 | Sentence | denotes | In the present study, the role of IL-2R signaling in the growth of CD8+ T cell prolymphocytic leukemia (T-PLL) cells has been investigated. |
| T4 | 490-730 | Sentence | denotes | Flow cytometry revealed that primary leukemia cells from a patient with CD8+ T-PLL expressed IL-2Ralpha and beta chains, and the cells showed a proliferative response and an increase in IL-2Ralpha expression on culture with exogeneous IL-2. |
| T5 | 731-841 | Sentence | denotes | Northern blot analysis failed to detect IL-2 mRNA, suggesting that IL-2 may act in a paracrine manner in vivo. |
| T6 | 842-1132 | Sentence | denotes | Electrophoretic mobility-shift assays revealed that recombinant IL-2 increased NF-kappaB binding activity in nuclear extracts of the leukemia cells, and Northern blot analysis showed that IL-2 increased the abundance of mRNAs encoding the NF-kappaB components c-Rel and KBF1 in these cells. |
| T7 | 1133-1310 | Sentence | denotes | IL-2 binding analysis demonstrated that IL-2 markedly increased the number of low affinity IL-2Rs on the leukemia cells, without an effect on the number of high-affinity IL-2Rs. |
| T8 | 1311-1508 | Sentence | denotes | These results show that IL-2 is capable of inducing the nuclear expression of NF-kappaB in primary CD8+ T-PLL cells, and that this effect is mediated, at least in part, at a pretranslational level. |
PubCasesHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TI1 | 50-58 | HP:0001909 | denotes | leukemia |
| AB1 | 444-452 | HP:0001909 | denotes | leukemia |
| AB2 | 527-535 | HP:0001909 | denotes | leukemia |
| AB3 | 975-983 | HP:0001909 | denotes | leukemia |
| AB4 | 1238-1246 | HP:0001909 | denotes | leukemia |
PubCasesORDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TI1 | 28-58 | ORDO:86871 | denotes | T cell prolymphocytic leukemia |
| AB1 | 422-452 | ORDO:86871 | denotes | T cell prolymphocytic leukemia |
| AB2 | 454-459 | ORDO:86871 | denotes | T-PLL |
| AB3 | 567-572 | ORDO:86871 | denotes | T-PLL |
| AB4 | 1415-1420 | ORDO:86871 | denotes | T-PLL |